Evidence map›Paper›PMID 20819951›Full record

ArticleThe Journal of biological chemistry2010

Liver cytochrome P450 3A ubiquitination in vivo by gp78/autocrine motility factor receptor and C terminus of Hsp70-interacting protein (CHIP) E3 ubiquitin ligases: physiological and pharmacological relevance.

Sung-Mi Kim, Poulomi Acharya, Juan C Engel, Maria Almira Correia

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sung-Mi KimDepartment of Cellular & Molecular Pharmacology, Bioengineering & Therapeutic Sciences and the Liver Center, University of California, San Francisco, California 94158-2517, USA.
Poulomi Acharya
Juan C Engel
Maria Almira Correia
Cellular Research (United States) · USUniversity of California, San Francisco · US

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
HEPATIC DEGRADATION OF P450P ISOZYMESR01GM044037 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CORREIA, MARIA ALMIRA · 1990 to 2023
$8.0M
REGULATION OF HEME METABOLISM IN THE LIVERR01DK026506 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CORREIA, MARIA ALMIRA · 1986 to 2016
$7.1M
Influence of Heme on Hepatic Cytochrome P450 Synthesis and DegradationR56DK026506 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CORREIA, MARIA ALMIRA · 2007 to 2007
$500k
NIDDK NIH HHS DK26506NIDDK NIH HHS P30 DK026743NIDDK NIH HHS P30DK26743NIDDK NIH HHS R01 DK026506NIDDK NIH HHS R56 DK026506NIGMS NIH HHS GM44037NIGMS NIH HHS R01 GM044037
6 · The paper itself

Abstract

CYP3A4 is a dominant human liver cytochrome P450 enzyme engaged in the metabolism and disposition of >50% of clinically relevant drugs and held responsible for many adverse drug-drug interactions. CYP3A4 and its mammalian liver CYP3A orthologs are endoplasmic reticulum (ER)-anchored monotopic proteins that undergo ubiquitin (Ub)-dependent proteasomal degradation (UPD) in an ER-associated degradation (ERAD) process. These integral ER proteins are ubiquitinated in vivo, and in vitro studies have identified the ER-integral gp78 and the cytosolic co-chaperone, CHIP (C terminus of Hsp70-interacting protein), as the relevant E3 Ub-ligases, along with their cognate E2 Ub-conjugating enzymes UBC7 and UbcH5a, respectively. Using lentiviral shRNA templates targeted against each of these Ub-ligases, we now document that both E3s are indeed physiologically involved in CYP3A ERAD/UPD in cultured rat hepatocytes. Accordingly, specific RNAi resulted in ≈80% knockdown of each hepatic Ub-ligase, with a corresponding ≈2.5-fold CYP3A stabilization. Surprisingly, however, such stabilization resulted in increased levels of functionally active CYP3A, thereby challenging the previous notion that E3 recognition and subsequent ERAD of CYP3A proteins required ab initio their structural and/or functional inactivation. Furthermore, coexpression in HepG2 cells of both CYP3A4 and gp78, but not its functionally inactive RING-finger mutant, resulted in enhanced CYP3A4 loss greater than that in corresponding cells expressing only CYP3A4. Stabilization of a functionally active CYP3A after RNAi knockdown of either of the E3s, coupled with the increased CYP3A4 loss on gp78 or CHIP coexpression, suggests that ERAD-associated E3 Ub-ligases can influence clinically relevant drug metabolism by effectively regulating the physiological CYP3A content and consequently its function.

Indexed as

UbiquitinationAnimalsCells, CulturedCytochrome P-450 CYP3AEndoplasmic ReticulumEnzyme StabilityHEK293 CellsHepatocytesHep G2 CellsHumansImmunoblottingLiverMaleMicroscopy, FluorescenceProteasome Endopeptidase ComplexRatsAMFR protein, humanCytochrome P-450 CYP3AProteasome Endopeptidase ComplexReceptors, Autocrine Motility FactorReceptors, CytokineStub1 protein, ratUbiquitin-Protein Ligases

Identifiers

PMID20819951
PMCPMC2975210
OpenAlexW2163881851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.